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Immune signatures of pathogenesis 
in the peritoneal compartment 
during early infection of sheep with 
Fasciola hepatica
Maria Teresa Ruiz-Campillo1, Veronica Molina Hernandez2, Alejandro Escamilla1, Michael 
Stevenson2, Jose Perez1, Alvaro Martinez-Moreno1, Sheila Donnelly3, John P. Dalton2 & 
Krystyna Cwiklinski2
Immune signatures of sheep acutely-infected with Fasciola hepatica, an important pathogen of 
livestock and humans were analysed within the peritoneal compartment to investigate early infection. 
Within the peritoneum, F. hepatica antibodies coincided with an intense innate and adaptive cellular 
immune response, with infiltrating leukocytes and a marked eosinophilia (49%). However, while 
cytokine qPCR analysis revealed IL-10, IL-12, IL-13, IL-23 and TGFβ were elevated, these were not 
statistically different at 18 days post-infection compared to uninfected animals indicating that the 
immune response is muted and not yet skewed to a Th2 type response that is associated with chronic 
disease. Proteomic analysis of the peritoneal fluid identified infection-related proteins, including 
several structural proteins derived from the liver extracellular matrix, connective tissue and epithelium, 
and proteins related to the immune system. Periostin and vascular cell adhesion protein 1 (VCAM-
1), molecules that mediate leukocyte infiltration and are associated with inflammatory disorders 
involving marked eosinophilia (e.g. asthma), were particularly elevated in the peritoneum. Immuno-
histochemical studies indicated that the source of periostin and VCAM-1 was the inflamed sheep liver 
tissue. This study has revealed previously unknown aspects of the immunology and pathogenesis 
associated with acute fascioliasis in the peritoneum and liver.
Fasciolosis is a disease of ruminants caused by the liver fluke Fasciola hepatica, and results in worldwide economic 
losses of greater than US $3 billion per annum1–3. It is also recognised by the World Health Organisation (WHO) 
as an important zoonosis; global infections are estimated between 2 and 17 million, with 180 million people at 
risk of infection4–6. The economic losses in ruminants are associated with the liver damage caused by parasites 
migrating through the definitive hosts resulting in poor food conversion, impaired fertility and reduced wool and 
milk production7–11.
Parasite migration begins following the ingestion of the infective encysted stage, the metacercariae, that 
excyst within the intestine as newly excysted juveniles (NEJs). The NEJs traverse the intestinal wall into the 
peritoneal cavity, where they continue to migrate through the liver capsule into the liver parenchyma. Those 
parasites that reach the liver, normally between four and six days post-infection, cause extensive tissue damage 
and haemorrhaging in the liver parenchyma resulting in the hepatic pathogenesis associated with acute fascio-
losis12. F. hepatica secretes molecules that modulate the host immune response and induce the development of a 
Th2 response and concomitant inhibition of protective pro-inflammatory responses as the disease progresses to 
chronicity12, 13. This polarisation of the immune responses is sufficiently potent to influence the host’s susceptibil-
ity to co-infections with bacterial pathogens13–19.
Acute fasciolosis is especially problematic in sheep that die suddenly from haemorrhage and liver damage, 
particularly when large numbers of migrating immature flukes enter the liver; according to the National Animal 
Disease Information Services (NADIS) it is estimated that up to 10% of sheep at risk of infection in the UK will 
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die of acute disease20. Clinical signs of infection include anaemia, dyspnoea, ascites and abdominal pain, which 
are also associated with sub-acute disease. Parasite populations resistant to the frontline anthelminthic used to 
treat acute fasciolosis, triclabendazole, are becoming more prevalent leaving farmers with no means of controlling 
acute infection21.
Studies have shown that as the parasite migrates through the intestinal epithelium clinical signs are not evi-
dent, although an immunological response is induced, as illustrated by the large number of immune cells infiltrat-
ing into the peritoneal cavity22, 23. Since the parasite migrates from the intestine to the liver via the peritoneum we 
considered that investigation of the peritoneal compartment of infected animals may provide new information of 
the early immune response in this compartment that can be exploited for vaccine development. At the same time, 
the data could also identify important host-specific proteins related to infection.
Proteomic analysis of the host response to F. hepatica has been carried out on host bile and serum24, 25, with 
the analysis of bile representing the chronic stages of infection when the adult parasites have migrated through 
the liver to the bile ducts24 and the serum representing the systemic response25. However, to date, the use of pro-
teomics tools for the analysis of peritoneal fluid has only been reported in patients with uremia, endometriosis, 
ovarian cancer and following cases of peritoneal dialysis26–29, which has facilitated the development of biomarkers 
for these respective diseases/pathologies.
In the present study, we examined the changes that occur within the peritoneal compartment of sheep during 
the first 18 days of infection (dpi) with F. hepatica. This is the first differential proteomic analysis of peritoneal 
fluid comparing uninfected and infected sheep. Our data reveal immune signatures within the peritoneum, with 
the identification of molecular markers of significant parasite-induced liver pathogenesis. These molecular mark-
ers may be useful for vaccine development studies in the future, particularly in relation to defining correlates of 
protective immune responses.
Results
Early liver pathology caused by the migration of immature Fasciola hepatica. No gross changes 
on either the diaphragmatic or visceral surface (Fig. 1A) were observed for the uninfected sheep. Liver from 
infected sheep (18 dpi) showed white/yellow foci and tortuous tracts ranging from 0.2–1.5 cm length located 
on the liver surface, mainly on the diaphragmatic aspect of the left lobe, consistent with F. hepatica infection 
(Fig. 1C). For some of the sheep, spots or small red tracts due to hyperaemia and haemorrhage could be observed.
At the microscopic level, histopathology revealed no hepatic damage in the uninfected sheep (Fig. 1B). In 
the infected animals, necrotic foci and necrotic tortuous tracts within the hepatic parenchyma, mainly involving 
Figure 1. Comparison of gross and microscopical liver pathology between uninfected (A and B) and infected 
(C and D) animals. (A) Liver showing no apparent gross pathology. (B) HE stained liver microphotograph 
showing centrilubular veins (c) and portal spaces (p) with blood vessels and bile ducts and absence of 
inflammatory infiltrate (Magnification x400). (C) Liver showing white tortuous tracts caused by F. hepatica. (D) 
HE stained liver microphotograph displaying acute small necrotic foci without inflammatory infiltrate (n), acute 
necrotic foci with presence of abundant necrotic inflammatory cells (ne) and severe inflammatory infiltrate in 
adjacent portal spaces (Magnification x400).
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sub-capsular areas were observed (Fig. 1D). Examination of the acute necrotic foci revealed a moderate inflam-
matory infiltrate, with a predominant infiltration of eosinophils and minimal infiltration of neutrophils (<1–2%), 
and peripheral focal haemorrhages. Portal spaces adjacent to necrotic foci showed severe inflammatory infiltrate 
suggesting that the route of the infiltrating inflammatory cells was through the portal vessels.
Liver enzyme analysis of the infected animals was consistent with the stage of liver fluke infection of the 
liver migrating parasites; elevated levels of glutamate dehydrogenase (GLDH) indicative of liver disease were 
observed, which were statistically significant when compared to the uninfected animals, based on normalised 
data (P value < 0.01). Furthermore, very low levels of gamma glutamyl-transferase (GGT), which is typically used 
as an indicator of chronic infection, were observed in both infected and non-infected groups (Fig. 2). Although 
the values observed for GLDH were significantly different between the groups, this was only observed when the 
data was normalised and large variation was observed between the animals suggesting that these serum enzymes 
may not be reliable markers for fasciolosis in sheep in the first 18 dpi. Analysis of liver enzymes within the perito-
neal fluid found lower levels of GLDH compared to serum and no significant differences between the uninfected 
and infected animals (data not shown). GLDH originates from hepatocytes located in the centrilobular area of 
the liver that express high levels of this enzyme and directly release it into the circulation making it more readily 
detected in serum30.
Immune signatures within the peritoneal compartment during acute F. hepatica infec-
tion. Using a combination of western blot and ELISA we evaluated the humoral immune response against F. 
hepatica in the peritoneal fluid of uninfected and infected animals (Fig. 3A,B). IgG antibodies against the recom-
binant F. hepatica antigen FhCL1 were markedly increased in the peritoneal fluid of infected sheep confirming F. 
hepatica infection (P value < 0.01). No FhCL1-specific antibodies were detected in uninfected sheep. This is the 
first report of the F. hepatica ELISA utilising FhCL1 being used for peritoneal fluid.
Analysis of the leukocyte profile found within the peritoneum revealed that the humoral response against F. 
hepatica coincides with a cellular immune response as observed by the statistically significant rise in total leuko-
cyte number within the peritoneal fluid, from a mean value of 6 × 106 ± 2.6 (SD) cells per ml in the uninfected 
animals to a mean value of 25 × 106 ± 15.6 (SD) cells per ml (P value < 0.05; Fig. 3C). In addition, the populations 
of individual cell types were dramatically altered; most notably, with 49% of the cell population comprised of 
eosinophils in the infected sheep compared to 2% in the uninfected sheep, which represented a 94-fold increase in 
the actual number of eosinophils at 18 dpi compared to uninfected sheep (P value < 0.01). Whilst the proportion 
of macrophages and lymphocytes in the total cell counts were reduced following infection (Fig. 3D), due to the 
4-fold increase in total cell count, the actual cell numbers increased 2-fold and 2.5-fold, respectively (Fig. 3E). 
There was also no evidence of mast cells or basophils within the cellular infiltrates, consistent with other studies 
in sheep31.
An extensive panel of ovine cytokines related to parasite infection were selected for qPCR analysis of the 
transcripts isolated from total peritoneal cells. Some primers were obtained from the literature, while others were 
designed as part of this study using available ovine cytokine gene sequences (Table 1). Cytokines IL-1, IL-4 and 
IL-5, and the chemokine Eotaxin were not detected in our samples from infected and non-infected animals. Five 
cytokines (IL-10, IL-12, IL-13, IL-23 and TGF-β) were shown to be more highly transcribed by the peritoneal cells 
from infected animals compared to cells taken from uninfected animals, relative to three housekeeping genes, 
β-actin, beta-2-microglobulin (B2M) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Fig. 4). These 
results were not shown to be statistically significant due to the high variability between the animals.
ECM proteins associated with infection and liver pathology. Comparative analysis of the perito-
neal fluid recovered from the uninfected and infected sheep identified a total of 176 proteins based on at least 
Figure 2. Liver enzyme profile. Serum from uninfected (UI) and infected (I) sheep, representing the mean 
(n = 5) of each group ± standard deviation were analysed for a variety of liver enzymes. The normalised data is 
shown by a dot plot on a log scale. Prot: total protein (g/l); Alb: albumin (g/l); Glob: globulin (g/l); GGT: gamma 
glutamyl-transferase (units/l) and GLDH: glutamate dehydrogenase (units/l). *P value = 0.01.
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Cytokine Forward sequence 5′-3′ Reverse sequence 5′-3′ Reference
IFN-γ ATCTCTTTCGAGGCCGGAGA ATTGCAGGCAGGAGAACCAT 110
IL-1 CACTGCCAGAAAATAAGCTGAAAC TGATCAAGCAAATCGCCTGAT 111
IL-4 GGAGCTGCCTGTAGCAGACG TTCTCAGTTGCGTTCTTTGGG 110
IL-5 CTGCTGATAGGTGATGGGAACTT GGTGATTTGTATGCTGAGGAGTAGG 110
IL-10 CTGAGAACCATGGGCCTGAC TCTCCCCCAGCGAGTTCAC 110
IL-12 GAATTCTCGGCAGGTGGAAG GTGCTCCACGTGTCAGGGTA 110
IL-13 AGAACCAGAAGGTGCCGCT GGTTGAGGCTCCACACCATG 110
IL-17 TGTGAGGGTCAACCTGAACAT TGATAATCGGTGGGCCTTCTG 111
IL-23 GGGAAGTGGACAGAGGTTCC CTGCCTCTCCAATCTGGGTG 112
TNF-α CCCGTCTGGACTTGGATCCT TGCTTTTGGTGCTCATGGTG 110
TGFβ1 GAACTGCTGTGTTCGTCAGC GGTTGTGCTGGTTGTACAGG 113
Arginase GCGGAAGTCAAGAAGACTGG AGGTTGTCCATGCAAGTTCC Current study±
iNOS TAGAGGAACATCTGGCCAGG TGGCAGGGTCCCCTCTGATG Current study^
Eotaxin ACAAGAAAATCTGTGTTGATCCCC CCATGGCATTCTGGACCC 111
B2M TTCTGTCCCACGCTGAGTTCA CAACCCAAATGAGGCATCGT *
Β-actin ACCAGTTCGCCATGGATGA AGCCGTTGTCAACCACGAG 110
GAPDH GGTGATGCTGGTGCTGAGTA TCATAAGTCCCTCCACGATG 111
Table 1. Primers for quantitative PCR (qPCR) cytokine analysis. *Pacheco, I.L., personal communication. 
±Based on Ovis aries arginase 1 (XM_004011324). ^Based on the bovine sequences from Adler et al.114 using  
the Ovis aries nitric oxide synthase 2 gene (XM_004012488).
Figure 3. Peritoneal fluid humoral and cellular analysis. (A) Detection of F. hepatica cathepsin L1 (FhCL1) 
specific antibodies in peritoneal fluid by immunoblotting. Lane 1: FhCL1 positive control; Lane 2: peritoneal 
fluid from the uninfected pool (UI_PF); Lane 3: peritoneal fluid from the infected pool (I_PF). (B) IgG level 
response in peritoneal fluid against F. hepatica cathepsin L1 (FhCL1). 1: FhCL1 positive control; 2: uninfected 
(UI_PF); 3: infected (I_PF). (C) Total mean cell count per ml in the peritoneal fluid from the uninfected 
(UI) and infected (I) groups (n = 5; ± standard deviation is represented). (D) Mean differential cell count 
showing the percentages of macrophages, lymphocytes, neutrophils and eosinophils in the peritoneal fluid of 
uninfected and infected sheep (n = 5; ± standard deviation is represented). (E) Mean differential cell count of 
macrophages, lymphocytes, neutrophils and eosinophils in the peritoneal fluid of uninfected and infected sheep 
(n = 5; ± standard deviation) represented by cell number. *P value < 0.05; **P value < 0.01.
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two unique peptides and the presence in both biological samples from experimental sheep trials carried out in 
Spain and the UK, which were classified according to putative function (Supplementary Table 1; Supplementary 
Fig. 1). Several structural proteins were identified related to the liver extracellular matrix (ECM), connective 
tissue and epithelium, including collagen VI structural unit proteins, fibronectin and fibrocystin, as well as pro-
teins related to the immune system including immunoglobulins and components of the complement system 
(Fig. 5). Of particular note were the ECM-related proteins that showed the highest fold change differences in the 
infected animals when compared with the uninfected animals, namely, periostin (fold change 5.8) and vascular 
cell adhesion protein 1 (VCAM-1; fold change 3) (Fig. 5B). Periostin is associated with several inflammatory dis-
orders and in particular, has been shown to be a systemic biomarker of airway eosinophilia in asthmatic patients 
being related with eosinophilic airway inflammation32, 33. VCAM-1, a leukocyte adhesion molecule expressed 
by cytokine-activated endothelial cells in culture, mediates mononuclear leukocyte infiltration in vessels and 
interstitium34. To confirm the presence of these proteins within the liver, we used an immunohistochemistry 
approach on sections of liver from the uninfected and infected sheep (Fig. 6). Periostin was found to be confined 
to the cytoplasm of hepatocytes and localised in the liver parenchyma in both the uninfected and infected animals 
(Fig. 6B,E and H, respectively). Interestingly, stronger periostin-related staining was observed in the hepato-
cytes surrounding the necrotic foci of infected animals. Furthermore, a moderate number of inflammatory cells 
were positive in the inner area of the acute necrotic foci and within the acute inflammatory infiltrate associated 
with the portal space (Fig. 6E and H). VCAM-1 was detected in the liver from infected animals, mostly in the 
inflammatory cells showing a reticular pattern; morphology compatible with dendritic cells within sites of acute 
inflammation. No VCAM-1 positive cells were found within the acute necrotic foci (Fig. 6F and I), compared with 
the very few positive cells with macrophage morphology localised in the portal spaces of the uninfected animals 
(Fig. 6C). Surprisingly, no VCAM-1 positive endothelial cells were detected in either the uninfected or infected 
animals.
Discussion
The migration of F. hepatica NEJ from the intestine to the liver is a critical step in the parasites’ establishment of 
infection in the mammalian host. Entry of the liver is accompanied by the development of the parasite gut, met-
abolic alterations, rapid growth and a marked regulation of expression of >8000 genes35. From the hosts’ point of 
view, penetration and migration through the liver provokes severe pathogenesis as a result of intense inflamma-
tory immune responses to fluke secretory antigens (including many proteases) and tissue damage. Prevention of 
tissue damage and inflammation is the primary aim of disease control; this makes the flukicide triclabendazole 
very attractive as a treatment since it is the only drug effective against the early migratory stages of the parasite. 
The spread of triclabendazole-resistant parasites, however, has left farmers without a means to control early and 
acute fasciolosis and consequently the disease has become increasingly prevalent in Europe and elsewhere12, 21, 36. 
Our focus is to develop an effective vaccine against F. hepatica that is directed at the early migratory stages to pre-
vent their penetration into, and migration within, the liver. For this, we need to further understand the immune 
response of the host to these early invasive stages, particularly in the vicinity of their migration i.e. the peritoneal 
cavity.
The immunological profile in the peritoneum during early stages of fasciolosis reflects that specific 
immune signatures can be identified within the ovine peritoneal compartment. Analysis of the peritoneal fluid 
showed a clear antibody response characterised by the presence of anti-FhCL1 (a secreted protease) antibod-
ies. Furthermore, there was intense cellular activity of both innate (macrophages, eosinophils) and adaptive 
Figure 4. Analysis of relative quantitative cytokine gene expression within the cells of the peritoneal fluid, 
represented by normalized relative fold expression on log10 scale. Immune marker transcript abundance of 
the infected group was normalised against the abundance of the respective transcripts in the uninfected group. 
Transcript abundance of the uninfected group (not shown on graph) is equal to 1. Data represents mean + SEM 
of fold changes in target transcript abundance relative to three house-keeping genes: β-actin, B2M and GAPDH. 
Each bar represents data from five biological replicates; statistical analyses were performed using One Way 
ANOVA with Tukey’s post hoc tests, comparing the data from the uninfected with infected samples, which 
showed no statistical differences based on animal variation within each group.
www.nature.com/scientificreports/
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(lymphocytes) immune cells. Most notable was the very marked eosinophilia (49% of immune cells). Eosinophilia 
is also observed within the peritoneum during the early stages of infection in rats37, and was observed by both 
histocytochemical studies22, 23, 38 and transcriptome analysis of F. hepatica-infected sheep liver39, 40. Marked 
eosinophilia is typical of helminth infections that drive Th2-dominant immune responses and in some cases, 
for example primary filarial infections41 and schistosomiasis42, 43, is associated with significant immune protec-
tion. However, the role of these cells in regulating immune responses to infection and their direct anti-parasite 
function is being heavily debated. Studies using eosinophil deficient mice infected with Schistosoma mansoni and 
Nippostrongylus brasiliensis have shown that the high levels of eosinophils may play a role in tissue remodelling 
rather than as agents of parasite damage (reviewed by44). Similarly Ohnmacht and colleagues45 suggest that the 
peritoneal cavity is a reservoir for eosinophils during helminth infection. Given the lack of resistance observed 
in sheep (reviewed by36) and our observations of marked eosinophilia within the peritoneum we would conclude 
they are not protective in primary responses in this species. Coupled with the lack of eosinophil degranulation 
proteins observed within the peritoneal fluid and the fact that the majority of the F. hepatica parasites at 18 dpi 
Figure 5. Expression profile of proteins identified within the peritoneal fluid relating to (A) blood, coagulation 
and the immune system, (B) cell cycle and cell adhesion, (C) collagen and cytoskeletal structure. The fold 
change, represented on a log 2 scale, was calculated based on the differences in protein concentration (emPAI 
values) between the uninfected and infected peritoneal fluid samples.
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are present within the liver, this implies that the peritoneal cavity acts as a reservoir for non-activated eosinophils 
that disseminate from here to other compartments.
F. hepatica infection studies in mice46, 47 and ruminants48–51 show that the immune response is dominated by 
a Th2-type response. However, most studies in ruminants have examined infections at patent or chronic stages 
when significant parasite development and host tissue damaged has occurred48, 49, 51. Our present study is the 
first to investigate early immune responses in the peritoneum compartment at a very early stage of infection. 
Our cytokine analysis of the mixed population of peritoneal cells by qPCR detected increased transcription of 
cytokines IL-12 and IL-23 that are associated with pro-inflammatory processes. Increased gene transcription 
of TGF-β and IL-10 was also observed in the infected animals, with TGF-β being implied in anti-inflammatory 
responses inducing fibrosis and tissue regeneration. TGF-β and IL-10 also play a central role in minimizing 
pathology and enhancing tissue repair during helminth infections52, 53. Interestingly, we did not observe IL-4, but 
perhaps transcription of this cytokine is down-regulated by TGF-β as seen in N. brasiliensis infections in mice 
whereby Treg–derived TGF-β counterbalanced IL-4 expression54. Similarly, in F. hepatica-infected mice only low 
levels of IL-4 transcription can be detected at 14 days post infection46. Overall, our data imply that, the immune 
responses initiated within this mixed population of cells, comprised of 20% lymphocytes, prior to 18 days of F. 
hepatica infection in sheep is weak and not differentiated to a Th2 type typical of chronic infection. The potent 
skewing towards a Th2 response appears only to occur after the parasite has penetrated the liver parenchyma and 
caused significant tissue damage (12; Cwiklinski et al., unpublished).
To further describe the immuno-pathological responses to F. hepatica infection and complement previous 
studies of the peritoneal compartment55–57, we employed a novel approach to identify the proteins present within 
sheep peritoneal fluid during early F. hepatica infection using proteomics. This was performed by electropho-
retically separating the proteins under denaturing conditions and then slicing fractions above and below the 
predominant host proteins (circa 67 kDa albumin; Supplementary Figure 1). While we likely missed proteins 
Figure 6. Immuno-labelling potential biomarkers of liver damage. Liver sections from uninfected (A,B,C) and 
infected sheep (D,E,F,H,I) were probed with periostin rabbit anti-mouse polyclonal antibody (B,E and H) and 
Vascular cell adhesion protein 1 (VCAM-1) rabbit anti-rat, mouse, human monoclonal antibody (C,F and I). 
Rabbit pre-immune serum (A and D) and staining using the goat anti-rabbit biotinylated secondary antibody 
only (G) were used as negative controls. Panels H and I are high powered images of panels E and F representing 
periostin and VCAM-1 staining, respectively. Periostin reactivity in the uninfected sheep (B) is found in the 
cytoplasm of hepatocytes, particularly in perilobular areas (arrows), whereas in the infected sheep (E and 
H) strong reactivity is found in hepatocytes (arrows) adjacent to inflammatory infiltrates (if) surrounding 
necrotic foci and in inflammatory cells (arrow heads). VCAM-1 is weakly expressed in the uninfected sheep 
(C) but strongly expressed in acute infection (F and I) particularly in the inflammatory infiltrates (if) showing 
a reticular pattern (arrow heads). ne: acute necrotic foci; if: inflammatory infiltrate; p: portal space. Scale bars 
represent 100 µm (A–G) and 50 µm (H and I).
www.nature.com/scientificreports/
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at similar migration to albumin we were able to identify 176 peritoneal fluid proteins. This data provides the 
first step to characterising the proteins that may play an important role in immunopathology and/or can act as 
biomarkers of infection. This study also reflects analysis of the host response following infection with different F. 
hepatica isolates, a UK isolate (South Gloucester) and an Italian isolate. Genetic analysis of these isolates has yet 
to be carried out, though recent studies have shown that F. hepatica is highly polymorphic and isolates within the 
UK show high levels of genetic diversity35, 58, indicating that these two isolates could exhibit differences. From the 
host’s point of view, comparative analysis of our proteomic data revealed a strong positive correlation between 
the biological replicates of each time-point (uninfected: r = 0.8799, P < 0.0001; infected: r = 0.7693, P < 0.0001), 
with the same proteins identified at comparable levels, based on emPAI values. As this study focussed on the early 
stages of infection, the number of parasites responsible for the infection cannot be quantified, so inferences of the 
virulence/pathogenicity of these isolates were not made as part of this study. However, based on similar pathology 
and immune responses across both experiments, these results indicate that despite potential genetic diversity, 
during the early stages of infection, the host response is comparable to each isolate.
The protein periostin is of particular interest because not only was it dramatically increased in the perito-
neal fluid of infected animals it was also particularly abundant in the cytoplasm of hepatocytes surrounding the 
necrotic foci, within inflammatory cells of the acute necrotic foci and within the acute inflammatory infiltrate 
associated with the portal space. As several cell types express periostin, including epithelial cells, fibroblasts (peri-
toneal and liver) and hepatocytes59–68, the source of periostin within the peritoneal fluid may be damaged liver 
tissues. Alternatively, the protein could be secreted by the peritoneal eosinophils that predominate in the cavity. 
Periostin has been shown to be involved in cellular dedifferentiation, ECM deposition and angiogenesis33, 63, 64, 
and within the liver where it plays a role in wound repair and tissue remodelling it co-localises with and binds to 
the ECM proteins fibronectin, tenascin C and fibrillar collagen (I, II, V) to form a connective tissue structure65. 
As well as being involved in fibrosis, periostin could also play a role in promoting eosinophil recruitment and 
migration within the ECM as observed in asthmatic studies32, 66–68. It has been suggested that soluble periostin 
may drive adhesion of eosinophils to ECM fibronectin increasing their survival68. Interestingly, expression of 
periostin is strongly associated with Th2-mediated pathologies69–71 and has been proposed as a biomarker for 
Th2-driven/eosinophilic inflammation66. For example, elevated levels of periostin can be detected in the serum of 
patients with acute or chronic hepatitis72.
The abundance of the adhesion protein VCAM-1 within the infected peritoneal cavity was supported by 
immunohistochemistry analysis that showed its enhanced expression in liver tissue of infected sheep compared to 
non-infected animals. This is consistent with other studies showing an increase in VCAM-1 expression associated 
with chronic liver and biliary diseases73. As observed in this study, VCAM-1 expression is low in resting, undam-
aged cells but during liver inflammation its expression increases, and is believed to be important for recruitment 
of monocytes and lymphocytes74–76. Cannistra et al.77 showed that functional VCAM-1 is expressed on activated 
mesothelial cells and may play a role in the distal arm of leukocyte trafficking to the abdominal cavity. Intestinal 
epithelial cells are also capable of expressing VCAM-1 during mucosal inflammation78, which could be released 
into the peritoneum following migration of the NEJs across the intestine.
We identified several components of the complement system (C1-C9) within our proteomic data. In particu-
lar, C1 g and s subcomponents and C3, together with the C4b binding protein were shown to be increased at 18 
dpi, with C3 being statistically upregulated (P value = 0.0029). C3 is the parent protein of C3a, which has shown 
to be an eosinophil chemo-attractant79 and therefore the proteolytic cleavage of this protein may be associated 
with the increase in peritoneal eosinophils we observed. The importance of the complement cascade system dur-
ing F. hepatica infection is further highlighted by liver transcriptome analysis performed by Alvarez-Rojas and 
colleagues39 that reported the upregulation of genes related to the complement system two weeks post infection, 
particularly the C4b binding protein. In vitro studies have shown that complement activation on the surface of 
juvenile stages of S. mansoni can mediate parasite killing80, 81. While studies have shown that parasites, including 
F. hepatica, are able to inhibit both the classical and alternative complement pathways as part of their survival 
strategies82, 83, the possible interaction between the complement cascade and F. hepatica NEJs warrants further 
investigation.
Our proteomic analysis also detected components of the liver ECM within the peritoneal fluid that are likely 
associated with the liver damage caused by the digestive activity of the migrating parasites. Collagen VI was par-
ticularly abundant, perhaps not surprisingly as it is found throughout the connective tissue, forming branching 
networks that bind to other ECM proteins. This networking-forming collagen increases during liver fibrosis, and 
an increase of its soluble form in the circulation of patients with chronic liver disease is often seen as a marker for 
tissue damage and hepatic fibrosis84–87. Collagen VI gene expression was also found to be upregulated in 8-week 
post F. hepatica infection sheep livers by Alvarez-Rojas and colleagues39, indicating its role in liver re-modelling 
following parasite infection.
Another early marker of liver damage is the increased expression and deposition of the adhesion protein 
fibronectin88–90, which is actively secreted by hepatic stellate cells in response to liver injury72. We observed 
increased levels of fibronectin within the peritoneal fluid, which together with collagen VI, may be released from 
the liver as the NEJ actively migrates through the connective tissue within the liver, rather than penetrating 
through the fibrillary collagen structures (collagen I, III & V) at this early stage.
The ability to uncover host-parasite interactions can now be complemented through the availability of exten-
sive bioinformatic datasets for both F. hepatica35, 91–93 and various definitive hosts of this parasite, including the 
bovine and ovine genomes94–96. Our particular study was made possible through the availability of the most recent 
Ovis aries genome96. In addition, studies analysing host-specific responses using transcriptomics are now being 
carried out40, 41, 97, 98. A recent study by Alvarez-Rojas and colleagues39 exploring the livers of F. hepatica infected 
sheep highlighted the transcriptomic changes observed within the liver eight weeks post infection, including sev-
eral upregulated genes linked to fibrosis (tgf-β related genes, calponin, transgelins and osteopontin) and markers 
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of a T-cell response (BCL6, CD86, IL1R2, IL18BP, IL27RA, TGFβ and TNF). Osteopontin together with perios-
tin, has been shown to mediate chronic rhinosinusitis inflammation by inducing a proliferative response of the 
ECM99. As fibrosis typically occurs four weeks post infection, periostin may be facilitating liver re-modelling 
without inducing fibrosis prior to the induction of other fibrosis-associated proteins, as has been observed in 
myocardial tissue100, 101. We observed no IFNγ expression at 18 dpi, which may be connected to IL18BP expres-
sion, a natural inhibitor of IFNγ102; a marker that requires further investigation. Although, the upregulation of 
TGFβ is consistent with our study, the remaining markers found to be upregulated at eight week post-infection 
are different, reflecting the different tissue/cells used for analysis and that the immune response profile changes 
during the course of infection.
Our study focussing at early infection in the peritoneum compartment has identified immune signatures asso-
ciated with early fasciolosis. Given that we have shown here that serum levels of GLDH and GGT are not reliable 
markers of liver damage prior to 18 dpi, and that immune responses have not yet differentiated, this study has iden-
tified new molecules associated with early F. hepatica infection at this stage. These biological markers may be useful 
in future diagnostics and also in vaccine development studies to define correlates of protective immune responses.
Methods
Ethical statement. All animal work carried out in Spain was approved by the Bioethical Committee of the 
University of Cordoba (1118) and was carried out according to the Directive 2010/63/EU and Spanish (Ley 6/2013) 
directives for animal experimentation. Experimental procedures at the Agri-Food and Biosciences Institute (AFBI; 
UK) were carried out under license from the Department of Health, Social Services and Public by the Animal 
(Scientific Procedures) Act 1986 (License No. PPL 2771), after ethical review by the AFBI Animal Ethics Committee.
Sheep infections. Trial one: Ten 8-month-old male Merino-breed sheep (Spain) were allocated in two 
groups; uninfected (n = 5) and infected (n = 5). The infected group was orally infected with 150 F. hepatica meta-
cercariae (South Gloucester isolate; Ridgeway Research Ltd) administered in gelatine capsules with a dosing 
gun. Animals were killed at 18 days post-infection (dpi) by intravenous injection of thiobarbital. At necropsy, 
the visceral and diaphragmatic aspects of the liver were photographed for gross evaluation. Tissue samples from 
the left and right hepatic lobes were fixed in 10% neutral buffered formalin and embedded in paraffin wax. For 
histopathology, 4 µm paraffin wax liver sections were stained with haematoxylin and eosin (HE).
Trial two: Ten 6 month-old male Dorset cross sheep (UK) were allocated in two groups; uninfected group 
(n = 5) and infected group (n = 5). The infected group was orally infected with 150 F. hepatica metacercariae 
(Italian isolate: Ridgeway Research Ltd) administered in water. Animals were euthanised at 18 dpi by captive bolt. 
At necropsy, the visceral and diaphragmatic aspects of the liver were photographed for gross evaluation.
Recovery of peritoneal fluid. Peritoneal washing was conducted as previously described by Zafra et al.22, 23. 
The recovered peritoneal fluid was centrifuged at 430 × g for 5 min and the supernatant and cell pellet retained. 
The cell pellet was re-suspended in 1 ml DPBS and erythrocyte contamination removed using an erythrolysis 
buffer (155 mM Ammonium chloride, 10 mM Potassium bicarbonate, 0.1 mM EDTA). Cell viability and total cell 
count was assayed by trypan blue staining. Cell smears stained using panoptic stain for the differential cell counts 
were also performed using Vectabond-treated slides to determine the percentage of macrophages, lymphocytes, 
neutrophils and eosinophils within the cell pellet. This was calculated as a percentage of 100 cells, using differen-
tial nucleus and cytoplasm colour granule morphology to determine cell type.
The peritoneal fluid supernatant was centrifuged as follows, discarding any recovered pellet at each step: (1) 
1720 × g for 10 min; (2) 25,000 × g for 30 min. Samples of the peritoneal fluid supernatants was concentrated 
(15-fold) by centrifugation in an Amicon Ultra-15 centrifugal filter unit (4000 × g at 4 °C), followed by a final 
centrifugation at 21,000 × g for 20 min at 4 °C. Equal protein concentrations (20 µg) from the concentrated peri-
toneal fluid supernatants were taken from the five animals of both the uninfected and infected groups, which were 
pooled for proteomic analysis.
Detection of anti-Fasciola hepatica cathepsin L1 (rFhCL1) antibodies in the peritoneal fluid by 
ELISA. Flat-bottom 96 well microtitre plates (Nunc MaxiSorp) were coated with 0.5 μg/ml of FhCL1 antigen 
and incubated overnight at 4 °C. After 3 washes with PBS 0.05% Tween 20 (PBST; pH 7.4), 200 μl/well of blocking 
buffer (5% skimmed-milk powder diluted in PBST) was added and incubated for 1 h at room temperature (RT). 
After washing 3 times, 100 μl of the rabbit anti-FhCL1103 and concentrated peritoneal fluid samples diluted 1:6400 
in PBST were added to the microtitre plates in triplicate and incubated for 1 h at 37 °C. After washing 4 times, 
the plate was incubated with 100 μl/well of 1:10,000 polyclonal donkey anti-sheep IgG conjugated to horseradish 
peroxidase (Novex) for 1 h at 37 °C. After washing 5 times, 100 μl TMB substrate (3,3′,5,5′-Tetramethylbenzidine 
Liquid Substrate Supersensitive) was added to each well. Following 15 min incubation the reaction was stopped 
with the addition of 100 μl 2 M sulphuric acid. A peritoneal fluid sample was considered to be positive when the 
OD-value, determined at a wavelength of 450 nm, was greater than the OD mean of peritoneal fluid samples from 
the uninfected group plus 2 standard deviations.
Detection of Fasciola hepatica cathepsin L1 (rFhCL1) specific antibodies in peritoneal fluid by 
immunoblotting. SDS-PAGE was performed using 4–12% NuPAGE Bis-Tris gels and 5 μg of recombinant 
FhCL1 in 50 µl of NuPAGE LDS sample buffer, followed by protein transfer to a nitrocellulose membrane (0.2 μm 
pore size). The nitrocellulose membrane was incubated in blocking buffer (5% skimmed-milk powder in TBST; 
20 mM Tris-HCl, 150 mM NaCl and 1% Tween20, pH 7.0) for 1 h at RT. The membranes were probed overnight 
at RT with a pool of concentrated peritoneal fluid from the uninfected and infected groups diluted 1:1000 in 
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TBST or as a positive control an anti-FhCL1 antibody103 diluted 1:1000 in TBST. Following 3 × 10 min washes in 
TBST, the membranes were probed with an alkaline phosphatase conjugated polyclonal donkey anti-sheep IgG 
antibody (Sigma) diluted 1:5000 for 1 h at RT, followed by 3 × 10 min washes in TBST. Immuno-reactive bands 
were visualised using NBT/BCIP (Sigma).
Serum levels of liver enzymes. Analysis of liver enzymes within the plasma of all animals was carried out 
for the following parameters: total protein, albumin, globulin, gamma glutamyl-transferase (GGT) and glutamate 
dehydrogenase (GLDH).
Quantification of the cytokine expression in peritoneal cells by quantitative PCR 
(qPCR). Messenger RNA (mRNA) was extracted from the peritoneal cells (3 × 106 cells) using QIAzol 
(Qiagen) followed by DNase treatment. First strand cDNA was synthesised using Superscript™ II RNase 
H-Reverse Transcriptase and random primers (Life Technologies). qPCR reactions were performed in 20 µl reac-
tion volume in triplicate, using 2 µl cDNA diluted 1:20, 10 µl of Platinum® SYBR® Green qPCR SuperMix-UDG 
kit (Life Technologies) and 1 µM of each primer (Table 1). qPCR was performed using the following cycling con-
ditions: 95 °C: 10 min; 39 cycles: 95 °C: 10 s, 55 °C: 15 s, 72 °C: 20 s; 72 °C: 5 min. Relative expression analysis was 
performed manually using Pfaffl’s Augmented ΔΔCt method104 whereby the comparative cycle threshold (Ct) 
values of the samples of interest are compared to a control and normalised to three housekeeping genes, β-actin, 
B2M and GAPDH, according to a modified tool from geNorm. In order for this method to be valid, amplifica-
tion efficiencies of individual reactions were verified using the comparative quantification package within the 
Rotor-Gene Q software v2.1.0. Annealing temperatures and melt-curve analysis was also carried out to check for 
single DNA products produced by these primer sets.
Mass spectrometry analysis of ovine peritoneal fluid. Pooled peritoneal fluid supernatant samples 
from the uninfected and infected groups from the two experimental trials were precipitated using trichloroacetic 
acid (TCA), followed by analysis by 1-DE using a 4–12% SDS PAGE (Criterion XT Bis-Tris; BioRad). In-gel 
trypsin digestion was carried out followed by ES/MS-MS analysis using an Ekspert NanoLC425 (Eksigent) cou-
pled to a 5600+ mass spectrometer (AB Sciex) equipped with a nanoelectrospray ion source. Peak list files were 
generated by Paragon and Progroup algorithms (Protein Pilot version 5.0; Sciex) using default parameters.
Database searching and criteria for protein identification. All MS/MS spectra were analysed with 
Mascot (version 2.4.0), against the Uniprot sheep protein databank (27174 entries), assuming digestion with 
trypsin with 2 missed cleavages permitted. Fragment and parent ion mass tolerance for Mascot were set at 
0.10 Da. Carbamidomethylation of cysteine was specified as a fixed modification and oxidation of methionine 
was specified as a variable modifications. Scaffold (version 4.6.2; Proteome Software Inc) was used to validate MS/
MS based peptide and protein identifications. Peptide identifications were accepted if they could be established 
at greater than 95% probability to achieve an FDR less than 1% by the Scaffold Local FDR algorithm105. Protein 
identifications were accepted if they could be established at greater than 95% probability to achieve an FDR less 
than 1% and contained at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet 
algorithm106. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis 
alone were grouped to satisfy the principles of parsimony.
Protein abundance was calculated by Scaffold software based upon the normalised exponentially modified 
protein abundance index (emPAI) protocol. A normalization minimum value of 0.05 was added to all values to 
compensate for null or zero values and to allow for log transformation of the data. The averages of the emPAI 
values from the biological replicates were used for statistical analysis of protein abundance, resulting in an overall 
fold change difference being calculated relative to the uninfected group. Multiple pairwise t-tests were performed 
in Scaffold; P value < 0.05 was deemed statistically significant.
Liver Immunohistochemistry (IHC). Three µm paraffin wax liver sections were analysed using the 
avidin-biotin-peroxidase complex (ABC) method. Tissue sections were dewaxed, rehydrated and endogenous 
peroxidase activity was exhausted by incubation with 0.3% hydrogen peroxide in methanol for 30 min at RT. 
Two different antigen retrieval pre-treatments were used107, 108: (1) Detection of periostin: 0.01 M sodium citrate 
buffer, pH 6, heated for 20 min; (2) Detection of VCAM-1: Tris-EDTA buffer, pH 9, heated for 30 min. Sections 
were washed in PBS (pH 7.2) and incubated with 20% normal goat serum (ImmunoPure) for 30 min at RT. 
Endogenous liver biotin was blocked using the Avidin/Biotin blocking kit (Vector Laboratories). Overnight incu-
bations at 4 °C were carried out using the following primary antibodies, rabbit anti-human periostin polyclonal 
antibody (LifeSpan BioSciences) and VCAM-1 rabbit anti-mouse monoclonal antibody (also cross reacts with rat 
& human; Abcam) both diluted 1:500 in PBS containing 10% normal goat serum. Following washing in PBS, the 
sections were incubated with the secondary antibody (goat anti-rabbit biotinylated antibody; Dako) diluted 1:200 
in PBS containing 10% normal goat serum for 30 min at RT. After washing in PBS, the sections were incubated 
with the ABC complex (Vectastain ABC Elite Kit) for 1 h at RT in darkness, washed in 0.05 M Tris buffered saline 
(pH 7.6) and then incubated in the chromogen solution (Vector NovaRED Peroxidase Substrate Kit). Finally, 
the sections were counterstained with Harris’ hematoxylin and mounted in Eukitt quick-hardening mounting 
medium (Sigma).
Statistical Analysis. Mann Whitney U tests and One Way ANOVA with Tukey’s post hoc tests performed on 
GraphPad Prism version 6.00 were used for statistical comparisons. P values of <0.05 was considered to be sta-
tistically significant. Correlation analysis of the proteomic data was performed on GraphPad Prism version 6.00.
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Accession Codes. The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE109 partner repository with the dataset identifier PXD005548 and 10.6019/PXD005548.
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